Clinical Trial Update: A Phase II Clinical Study of Utidelone and Bevacizumab With or Without Etoposide in Patients With Brain Metastases From Malignant Solid Tumors [Phase 2]

View source ↗

Summary

A Phase II clinical study evaluating Utidelone and Bevacizumab, with or without Etoposide, in patients with brain metastases from malignant solid tumors; the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Bevacizumab (bevacizumab)
• Etoposide (Etoposide)
• Utidelone (utidelone)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Malignant Solid Tumor, Brain Metastasis | Phase 2 | Status: NOT_YET_RECRUITING